Biogen Inc (NASDAQ: BIIB) is making its way into the green this mroning after announcing a buyback program. The program comes after the company saw a painful drop in value after announcing the discontinuation of a clinical study. Today, we’ll talk about: The BIIB stock buyback program; what we’re seeing from the stock in the … Read more
Biogen Inc (NASDAQ: BIIB) is falling hard in the pre-market hours this morning, and for good reason. The company announced that it would be putting an end to a Phase 3 development program, upsetting investors and sending the stock tumbling down. Today, we’ll talk about: The scrapped development program; what we’re seeing from BIIB stock … Read more
Biogen Inc (NASDAQ: BIIB) is falling hard early on in the pre-market this morning, and the declines may be confusing to some. That’s because the comapny released clinical results this morning that seemed to be overwhelmingly positive. With positive results in mind, stocks usually head up. So, what’s the deal here? Today, we’ll talk about: … Read more
Biogen Inc (NASDAQ: BIIB) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced its earnings for the second quarter, beating expectations. The news also comes ahead of the company’s Alzheimer’s presentation. Of course, the strong earnings and coming catalysts are points of excitement for investors who … Read more
Ionis Pharmaceuticals Inc (NASDAQ: IONS) is headed for the top in the pre-market hours this morning after announcing an expanded collaboration with Biogen Inc (NASDAQ: BIIB). Of course, the news that the collaboration between the two companies is expanding is exciting to investors who are pushing the stock upward. Today, we’ll talk about: The expanded collaboration; … Read more
Biogen Inc (NASDAQ: BIIB) is having an incredibly strong time in the pre-market hours this morning, and for good reason. The company released data showing positive real-world experiences among patients using its leading MS therapies. As a result, investor excitement ensued and the stock found its way upward. As is almost always the case, our partners … Read more
Biogen Inc (NASDAQ: BIIB) Biogen is having an interesting day in the market today, to say the least. At the opening bell, the stock was trading in the green. From there, it dipped down a bit, but caught itself before going red. Nonetheless, things changed in a big way minutes ago as the stock started … Read more
Biogen Inc (NASDAQ: BIIB) Biogen stock is getting whacked in sympathy to Eli Lilly’s announcement that it has once again failed in its quest to prove solanezumab to be a viable treatment for Alzheimer’s patients. Is The Hatchet Job On BIIB Warranted? While trading in sympathy is common on Wall Street, it exemplifies the fact … Read more
Amyris Inc (NASDAQ: AMRS) | Biogen Inc (NASDAQ: BIIB) Amyris is having an incredible day in the market today, and for good reason. The company announced that it has entered into an agreement with Biogen. Today, we’ll talk about the details of the agreement, how the stock reacted to the news, and what we can … Read more
Biogen Inc (NASDAQ: BIIB) Biogen is one of the larger biotech companies on the market today. However, as of late, the company has struggled to keep its stock above water as Tecfidera sales have declined after the emergance of a progressive multifocal leukoencephalopathy or PML-related death while taking the MS drug. Another case of PML … Read more